Currently, there are 286.84M common shares owned by the public and among those 267.47M shares have been available to trade.
The company’s stock has a 5-day price change of -15.70% and -46.41% over the past three months. CAN shares are trading -66.28% year to date (YTD), with the 12-month market performance down to -36.58% lower. It has a 12-month low price of $0.53 and touched a high of $3.27 over the same period. CAN has an average intraday trading volume of 20.37 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.50%, -12.95%, and -48.42% respectively.
Institutional ownership of Canaan Inc ADR (NASDAQ: CAN) shares accounts for 26.69% of the company’s 286.84M shares outstanding.
It has a market capitalization of $198.29M and a beta (3y monthly) value of 3.40. The earnings-per-share (ttm) stands at -$1.02. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.55% over the week and 7.68% over the month.
Analysts forecast that Canaan Inc ADR (CAN) will achieve an EPS of -0.51 for the current quarter, -0.36 for the next quarter and 2.75 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.58 while analysts give the company a high EPS estimate of -0.58. Comparatively, EPS for the current quarter was -0.06 a year ago. Earnings per share for the fiscal year are expected to increase by 96.54%, and 1107.06% over the next financial year.
Looking at the support for the CAN, a number of firms have released research notes about the stock. The Benchmark Company stated their Buy rating for the stock in a research note on May 06, 2025, with the firm’s price target at $3. Compass Point coverage for the Canaan Inc ADR (CAN) stock in a research note released on March 18, 2025 offered a Buy rating with a price target of $2.50. B. Riley Securities was of a view on September 18, 2024 that the stock is Buy, while Rosenblatt gave the stock Buy rating on September 11, 2024, issuing a price target of $3. H.C. Wainwright on their part issued Buy rating on July 06, 2022.
